Global DNA Sequencing Markets, 2020-2021, 2021-2024 & 2030
Dublin, Nov. 15, 2021 (GLOBE NEWSWIRE) -- The "DNA Sequencing - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
This report briefly reviews the basics of human genome variations, development of sequencing technologies, and their applications.
The current market is mostly for research applications and future markets will be other applications related to healthcare. The value of the DNA sequencer market in 2020 is described with estimates for 2024 and 2030.
Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery, and cancer. Next-generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for the analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.
Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.
The report includes profiles of 150 companies involved in sequencing and their 173 collaborations. The report text is supplemented by 42 tables, 24 figures, and 500 selected references to the literature.
Current Status and Future Prospects
ACMG clinical laboratory standards for NGS
Regulatory and quality control issues of sequencers in the USA
International NGS standardization
Applications of NGS in clinical trials
Human transcriptome array in clinical trials
Challenges for clinical applications of NGS
Direct-to-consumer WGS services
Ethical aspects of sequencing
Future trends in clinical sequencing
Rare Diseases Genomes Project
Markets for Sequencing
Introduction
Methods used for estimation of sequencer markets
Currently marketed sequencers
Academic and research markets for sequencing
Factors affecting future development of sequencing markets
Future needs and support of research
Bioinformatics in relation to sequencing
Cost of integrating WGS into clinical care
Reducing the cost of human genome sequencing
US Government-supported research on sequencing
Contribution of American Recovery and Reinvestment Act
Cost of NGS
Genome X Prize Foundation
Innovations to reduce cost of whole genome sequencing
Commercial aspects of low-cost genome sequencing
NGS for personalized medicine
Global sequencing markets
Global markets for sequencers
Markets for sequencing services according to geographical regions
Global sequencing markets according to applications
Global sequencing markets according to therapeutic areas
NGS markets for cancer
NGS markets for genetic disorders
NGS markets for microbiome
Market trends for NGS
Needs of the clinical market for NGS
Sequencers for the clinical market
Challenges to developing market for sequencers
Recommendations
Comparative Analysis of Sequencing Technologies
General findings of the study
Sanger versus second generation marketed sequencers
Common features and differences among second generation sequencers
Third generation large sequencers
SOLiD4 versus competing large sequencers
Illumina's HiSeq sequencer
Third generation desktop sequencers
BGI's BGISEQ-500 desk top sequencer
Illumina's MiSeq sequencer
Roche GS Junior System
Life Technologies' Benchtop Ion ProtonT Sequencer
Oxford Nanopore's MinIONT system
The ideal desk-top sequencer
SWOT analysis of small sequencers
Concluding remarks on SWOT analysis of desktop sequencers
Key Topics Covered:
Part I: Technologies & Applications
Executive Summary
1. Introduction
2. DNA Sequencing Technologies
3. Role of Bioinformatics in Sequencing
4. Comparative Analysis of Sequencing Technologies
5. Sequencing for Research
6. Applications of Sequencing in Healthcare
7. Applications of Sequencing in Oncology
8. Sequencing in Genetic Disorders
9. Sequencing in Neurological and Psychiatric Disorders
10. Applications of sequencings in infections
11. Role of Sequencing in Personalized Medicine
12. Current Status and Future Prospects
Part II: Markets & Companies
13. Markets for Sequencing
14. Companies Involved in Sequencing
15. References
For more information about this report visit https://www.researchandmarkets.com/r/157vyg
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900